AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.150

-0.005-3.23%

Volume:10.00K

Turnover:2K

Market Cap:24.77M

PE:-2.09

High:0.150

Open:0.150

Low:0.150

Close:0.155

52wk High:0.860

52wk Low:0.098

Shares:165.12M

Float Shares:121.55M

Volume Ratio:0.14

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.072

EPS(LYR):-0.060

ROE:-155.68%

ROA:-66.70%

PB:3.33

PE(LYR):-2.48

Loading ...

Overview Company News Filings

Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million

Proteomics International Laboratories - FY Revenue A$3.6 Mln

THOMSON REUTERS

Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Australia's Proteomics International Soars on Distribution Deal with Healius

Proteomics International Laboratories - Signs National Distribution Agreement with Healius for Promarker Portfolio

THOMSON REUTERS

ASX Penny Stocks Spotlight Aroa Biosurgery And Two More Hidden Gems

Simply Wall St.

Australia's Proteomics Climbs on US Patent for Endometriosis Test

Proteomics International Laboratories - Secures US Patent Grant for Endometriosis Innovative Diagnostic Test

THOMSON REUTERS

Proteomics International Laboratories Says Restructure, Executive Appointment And Board Update

Proteomics International Laboratories Ltd - Cuts 25% of Positions, Expects Over a$1 Mln Annualised Cost Savings

THOMSON REUTERS

Proteomics International Laboratories Ltd-Restructure, Executive Appointment and Board Update

THOMSON REUTERS

Proteomics International Laboratories Ltd - Appoints Tim Luscombe as Chief Financial Officer

THOMSON REUTERS

Here's Why We're Watching Proteomics International Laboratories' (ASX:PIQ) Cash Burn Situation

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/PIQ.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PIQ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.15,"timestamp":1788156720000,"preClose":0.155,"halted":0,"volume":10000,"delay":0,"changeRate":-0.03225806451612906,"nameEN":"PROTEOMICS INTERNATIONAL LAB","floatShares":121549097,"shares":165116433,"eps":-0.071612,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"08-31 16:12:00 AEST","open":0.15,"high":0.15,"low":0.15,"amount":1500,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.071612,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.155,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":0.14146832831087097,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PIQ.AU","preClose":0.155,"auctionPrice":0.155,"auctionVolume":10533,"auction":3,"marketStatus":"盘后竞价","timestamp":1787897392582}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":121549097,"roa":"-66.70%","roe":"-155.68%","lyrEps":-0.060439,"volumeRatio":0.14146832831087097,"shares":165116433,"dividePrice":0,"high":0.15,"amplitude":0,"preClose":0.155,"low":0.15,"week52Low":0.098,"pbRate":"3.33","psRate":"7.73","week52High":0.86,"institutionHeld":0,"latestPrice":0.15,"eps":-0.071612,"divideRate":0,"volume":10000,"delay":0,"ttmEps":-0.071612,"open":0.15,"prevYearClose":0.655,"prevWeekClose":0.155,"prevMonthClose":0.15,"prevQuarterClose":0.115,"fiveDayClose":0.165,"twentyDayClose":0.135,"sixtyDayClose":0.135},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663784060","title":"Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663784060","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663784060?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:44","pubTimestamp":1788162262,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Posts FY Loss Attributable A$8.6 MillionAug 31 -Proteomics International Laboratories LtdPIQ.AX:FY LOSS ATTRIBUTABLE A$8.6 MILLIONFY REVENUE A$3.6 MILLIONTHERE WERE NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFurther company coverage:PIQ.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","PIQ.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663272890","title":"Proteomics International Laboratories - FY Revenue A$3.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663272890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663272890?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663027285","title":"Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663027285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663027285?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653782201","title":"Australia's Proteomics International Soars on Distribution Deal with Healius","url":"https://stock-news.laohu8.com/highlight/detail?id=2653782201","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653782201?lang=en_us&edition=fundamental","pubTime":"2026-07-22 09:42","pubTimestamp":1784684561,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics International soars on distribution deal with Healius** Proteomics InternationalPIQ.AXrise as much as 50% to A$0.225, their highest level since May 6**Signsexclusive pathol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4N43O04Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","BK7509","BK7508","BK7501","BK7048","HLS.AU","PIQ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653789304","title":"Proteomics International Laboratories - Signs National Distribution Agreement with Healius for Promarker Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2653789304","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653789304?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:30","pubTimestamp":1784673025,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N16X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651431534","title":"ASX Penny Stocks Spotlight Aroa Biosurgery And Two More Hidden Gems","url":"https://stock-news.laohu8.com/highlight/detail?id=2651431534","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651431534?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:05","pubTimestamp":1784081103,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest advance, buoyed by positive U.S. bank earnings and easing consumer prices, although geopolitical tensions continue to cast a shadow. In the current market landscape, where traditional investments face uncertainties, penny stocks offer an intriguing alternative with their potential for growth and value. Despite being perceived as relics of past trading days, these smaller or newer companies can still present significant opportunities when backed by...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/asx-penny-stocks-spotlight-aroa-biosurgery-and-two-more-hidd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/asx-penny-stocks-spotlight-aroa-biosurgery-and-two-more-hidd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","BK7048","PIQ.AU","FEX.AU","BK7129","ARX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649954004","title":"Australia's Proteomics Climbs on US Patent for Endometriosis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2649954004","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649954004?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:24","pubTimestamp":1783481076,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics climbs on US patent for endometriosis test** Shares of Proteomics International LaboratoriesPIQ.AXclimb as much as 41.9% to A$0.22, their biggest intraday pct rise since ea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nL6N43A07F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955158","title":"Proteomics International Laboratories - Secures US Patent Grant for Endometriosis Innovative Diagnostic Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649955158?lang=en_us&edition=fundamental","pubTime":"2026-07-08 08:10","pubTimestamp":1783469404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN4390Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628225485","title":"Proteomics International Laboratories Says Restructure, Executive Appointment And Board Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2628225485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628225485?lang=en_us&edition=fundamental","pubTime":"2026-04-17 09:43","pubTimestamp":1776390209,"startTime":"0","endTime":"0","summary":"April 17 (Reuters) - Proteomics International Laboratories Ltd ::*RESTRUCTURE, EXECUTIVE APPOINTMENT AND BOARD UPDATE*APPOINTS TIM LUSCOMBE AS CHIEF FINANCIAL OFFICER*CUTS 25% OF POSITIONS, EXPECTS OV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nRSD6mt0Lr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628924717","title":"Proteomics International Laboratories Ltd - Cuts 25% of Positions, Expects Over a$1 Mln Annualised Cost Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2628924717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628924717?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:21","pubTimestamp":1776381715,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUE9TBQTD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628247169","title":"Proteomics International Laboratories Ltd-Restructure, Executive Appointment and Board Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2628247169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628247169?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:21","pubTimestamp":1776381715,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUE9TBQTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628176247","title":"Proteomics International Laboratories Ltd - Appoints Tim Luscombe as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628176247","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628176247?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:21","pubTimestamp":1776381715,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUE9TBQTD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","PIQ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627447653","title":"Here's Why We're Watching Proteomics International Laboratories' (ASX:PIQ) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2627447653","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627447653?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:44","pubTimestamp":1776203063,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/heres-why-were-watching-proteomics-international-laboratorie","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/heres-why-were-watching-proteomics-international-laboratorie","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7048","PIQ.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}